Jie Deng

ORCID: 0000-0002-2553-8822 · 6 papers in corpus
review 2026
International journal of women's health ·doi:10.2147/ijwh.s636972

This narrative review first summarizes current treatment strategies and postoperative prevention measures for intrauterine adhesions (IUAs), then discusses prognostic factors associated with pregnancy outcomes and recent advances in predict…

observational 2025
Archives of gynecology and obstetrics ·doi:10.1007/s00404-025-08025-3

OBJECTIVE: To evaluate the clinicopathologic characteristics and survival outcomes of ovarian clear cell carcinoma (OCCC) patients with different endometriosis statuses. METHODS: This retrospective study included OCCC patients diagnosed be…

meta-analysis 2022
Frontiers in oncology ·doi:10.3389/fonc.2022.944494

Chemokines are a class of pro-inflammatory cytokines that can recruit and activate chemotactic cells. C-X-C motif chemokine ligand 5 (CXCL5) is a member of the chemokine family binding CXCR2 (C-X-C Motif Chemokine Receptor 2), a G-protein c…

review 2021
BioMed research international ·doi:10.1155/2021/1516855

Acute pancreatitis (AP) is an inflammatory disease of the pancreas. The severity is classified as mild (MAP), moderately severe (MSAP), or severe (SAP). In patients with SAP, organ dysfunction can occur in the early stage of the disease cou…

meta-analysis 2017
Oncotarget ·doi:10.18632/oncotarget.15759

Ovarian reserve reflects a woman's fertility potential. The ABO blood group system is a very stable genetic marker. Although many recent studies have explored the relationship between ABO blood group and ovarian reserve, a consensus has not…

meta-analysis 2017
Oncotarget ·doi:10.18632/oncotarget.14173

Urine HE4 has been reported as the potential novel diagnostic biomarker for ovarian cancer in several studies, but their results were inconsistent. Therefore, we conducted a systematic analysis to evaluate the diagnostic value of urine HE4 …